The jellyfish protein aequorin with its co-factor, coelenterazine, has been used for over 3 decades to measure cytosolic calcium ([Ca 2ϩ ] i ) 1 (1) . Although microinjection of the purified protein in early studies made its use technically challenging, the dynamic range of aequorin has always recommended it for studies of physiological transitions in [Ca 2ϩ ] i (1) . The cloning of one of the members of this family of proteins made it possible to transiently transfect cells with cDNAs encoding aequorin and thereby circumvent the need for microinjection (2, 3) . Recently, aequorin has been creatively applied to the measurement of Ca 2ϩ in discrete cellular subdomains, such as the near mitochondrial membrane (4 -6) and the endoplasmic reticulum (7, 8) , by creating chimeras of targeting sequences of intracellular organelle marker proteins with aequorin. This offers a clear advantage of selective measurement of [Ca 2ϩ ] i in various subcellular domains over the current alternative of fluorescent dyes that are distributed uniformly in the cytosol. Ca 2ϩ -sensitive adenylyl cyclases (even when transfected heterologously) are directly regulated by changes in [Ca 2ϩ ] i (9, 10 Plasmids-The mammalian expression vector pcDNA3 (Invitrogen, San Diego, CA) was used to express mouse ACVI, HA1-tagged aequorin (cytAEQ), and the ACVI-and HA1-tagged aequorin (ACVI/AEQ) chimera. The construction of ACVI, which contains the coding sequence of mouse type VI adenylyl cyclase in pBluescript II SK(Ϫ) (Stratagene, La Jolla, CA), was described previously (13) . This cDNA was excised with KpnI and BamHI and ligated into pcDNA3. The cytAEQ cDNA in pBS(ϩ), kindly provided by Dr. R. Rizzuto (University of Padova, Padova, Italy) (4), was released by SalI and EcoRI digestion and ligated into pBluescript II SK(Ϫ). This cDNA was excised with XbaI (a flanking vector site) and introduced into pcDNA3. The cytomegalovirus promoter of pcDNA3 directs expression of the protein.
Construction of ACVI/AEQ Chimeric cDNA-ACVI/AEQ chimeric cDNA was engineered by two-stage PCR, combining two separate PCR products with overlapping sequence into one longer product (Ref. 14; see Fig. 1 ). The sequences of the oligonucleotide primers were as follows: primer 1, ctcgctcgcccaTGACCAGGTCGGCCGCTCACACAT, 5Ј sense to ACVI including an AspI restriction site located at nucleotide 3235 (uppercase letters) and the sequence of the pDirect vector (CLON-TECH Laboratories, Palo Alto, CA) (lowercase letters); primer 2, ataatcaggaacatcataACTGCTGGGGCCCCCGTT, 3Ј antisense to ACVI, including the C terminus (uppercase letters), overlapped with cytAEQ (lowercase letters); primer 3, AACGGGGGCCCCAGCAGTtatgatgttc-ctgattat, 5Ј sense to cytAEQ, including the N terminus (lowercase letters), overlapped with ACVI (uppercase letters), complementary to primer 2; primer 4, ctggttcggcccaTTAGGGGACAGCTCCACCGTAGA, 3Ј antisense to cytAEQ (uppercase letters) and the pDirect sequence (lowercase letters). The first stage PCR generated two fragments separately. One was the 3Ј segment of ACVI cDNA encoding amino acids 1045-1165, including the AspI restriction site, and also cDNA encoding the first 6 amino acids of cytAEQ, obtained by using primers 1 and 2 and ACVI cDNA as the amplification target. The other was the cytAEQ cDNA encoding the whole photoprotein and cDNA encoding the last 6 amino acids of ACVI, obtained by using primers 3 and 4, and cytAEQ cDNA as the amplification target. In the second stage PCR, after gel purification, the two overlapping fragments were mixed in equimolar amounts along with primers 1 and 4. The PCR construct was subcloned into pDirect (CLONTECH), and the sequence was confirmed by DNA sequencing, using the dideoxynucleotide chain termination method with modified T7 DNA polymerase (Sequenase, U.S. Biochemical Corp.) (15). The PCR construct was then excised by double digestion with AspI and XbaI and ligated with the 5Ј part of ACVI cDNA in the pBluescript II SK(Ϫ) vector, cut with AspI and XbaI. Finally, the ACVI/AEQ chimeric cDNA was excised from pBluescript II SK(Ϫ) with EcoRI and XbaI and introduced into pcDNA3.
Cell Culture and Transfection of HEK 293 Cells-HEK 293 cells maintained as described previously (12) were transiently transfected at about 50% confluency, using the calcium phosphate method (16) with 26 g of plasmid DNA for each transfection. Seventeen hours after transfection, the cells were harvested and replated either (i) onto 24-well culture plates and incubated for 2 days before cAMP measurements were made, or (ii) onto 100-mm culture plates for 48 h for aequorin measurements.
Cell Fractionation-HEK 293 cells, transfected with vector alone, ACVI, or ACVI/AEQ plasmids, were lysed using a modification of a glycerol-stabilized lysis method (17, 18) . The lysate from six 75-cm 2 flasks was adjusted to 3% sucrose, layered on top of linear sucrose gradients (5-45%), and centrifuged at 27,000 rpm (1 h, 4°C, SW28 rotor; Beckman Instruments, Palo Alto, CA). The gradients were fractionated and analyzed for adenylyl cyclase activity (19, 20) , marker enzymes (cytochrome c oxidase, mitochondria; 5Ј-nucleotidase, plasma membrane; lactate dehydrogenase, cytosol; Refs. 21 and 22), protein concentration, and sucrose.
Adenylyl Cyclase Assays and cAMP Determinations-Adenylyl cyclase activity was measured in aliquots of the fractionated gradients as described previously (19, 20) . The incubation mixture included 100 mM Tris, pH 7.6, [␣- The Ca 2ϩ sensitivity of transfected adenylyl cyclases was determined as described previously (19, 20) . Purified membranes from transfected HEK 293 cells or crude cerebral cortical membranes (4 -10 g of protein/assay) were incubated (30°C, 30 min, 100 l) in a mixture similar to that described above but also containing a range of (60 M) EGTAbuffered free [Ca 2ϩ ] at pH 7.4. Adenylyl cyclase activity in HEK 293 cells was measured in the presence of 10 M prostaglandin E1 and 20 M forskolin, while cortical AC activity was assayed with only 1 M calmodulin. Data (mean Ϯ S.E. of triplicate determinations) are expressed in pmol/min and are corrected by the concentration of protein.
cAMP accumulation in intact cells was measured as described previously (11, 12) with some modifications. The ATP pool of HEK 293 cells on 24-well plates was labeled in minimal essential medium (60 min, 37°C) with [2] [3] H]adenine (1.5 Ci/well). After washing, the cells were incubated with a nominally Ca 2ϩ -free Krebs buffer (12) . The use of Ca 2ϩ -free Krebs buffer in experiments denotes the addition of 0.1 mM EGTA to the nominally Ca 2ϩ -free Krebs buffer. All experiments were carried out at 37°C in the presence of the phosphodiesterase inhibitors 3-isobutyl-1-methylxanthine (500 M) and Ro 20 -1724 (100 M), which were preincubated with the cells for 10 min prior to a 1-min assay. Assays were terminated, and samples were processed as described previously (23) .
Aequorin Measurements-Aequorin measurements were carried out 48 h after transfection. The in vitro [Ca 2ϩ ] calibration curves were determined by exposing cell lysates of HEK 293 cells transfected with either the cytAEQ or ACVI/AEQ plasmids to solutions of EGTA-buffered [Ca 2ϩ ] as follows. The cells were resuspended in a lysis buffer containing 100 mM HEPES, 0.2 mM EGTA, 0.2% bovine serum albumin, 0.3 mM phenylmethylsulfonyl fluoride, protease inhibitor mixture as described previously (24), pH 7.0, and lysed through a 25-gauge syringe. Cell membranes were separated from cell lysate by centrifugation (20 min, 4°C, 12,000 rpm, Sorvall SS34). The supernatant (cell lysate) was utilized for in vitro calibration of cytAEQ, and the cell pellet (cell membranes) was utilized for in vitro calibration of ACVI/AEQ. Apoaequorin was reconstituted with 5 M coelenterazine (Molecular Probes) for 2-2.5 h at 4°C in the presence of 1% ␤-mercaptoethanol. Cell lysate or cell membranes were diluted into an intracellular-like buffer containing the following final concentrations: 130 mM KCl, 10 mM NaCl, 1 mM MgSO 4 , 0.5 mM K 2 HPO 4 , 1 mM ATP, 0.2% bovine serum albumin, 100 mM HEPES, pH 7.0, at 22°C, supplemented with 0.1 mM EGTA and different amounts of total CaCl 2 , as in the cyclase assays, above. Ca 2ϩ buffers of various concentrations were injected into the chamber, and the light emission was recorded. For in vivo measurements, transfected cells were washed and loaded with 5 M coelenterazine (Molecular Probes) in minimal essential medium supplemented with 1% fetal calf serum and 0.5 mM EGTA for 2 h at 37°C in 5% CO 2 in the dark. Cells were resuspended in nominally Ca 2ϩ -free Krebs buffer at pH 7.4 supplemented with 75 M Ca 2ϩ , and 0.2 mM EGTA was added immediately prior to measurements. Aequorin luminescence was measured in a Berthold Lumat LB 9501 luminometer (EG & G Berthold, Bad Wildbad, Germany) and collected in ascii format on an 80486 microprocessor. The L max was found by integrating a continuous recording of aequorinmediated light emission from transfected cells in the presence of 0.2% Triton X-100 and 10 mM Ca 2ϩ until the light emission returned to basal levels, and subsequent injections of Triton X-100 and Ca 2ϩ were unable to produce further increases in light emission. This back-calculation strategy also corrected for any variability in the degree of expression of the cytAEQ or ACVI/AEQ proteins (6) . Luminescence values determined in vivo were transformed into [Ca 2ϩ ] i values using an algorithm based on the reordering of an equation (25) described by Allen et al. (26) . The light output from transfected cells loaded in the absence of coelenterazine or from mock-transfected cells loaded with coelenterazine was not significantly higher than background.
RESULTS
The design chosen for the adenylyl cyclase/aequorin chimera was to place aequorin, linked at the N terminus with the HA1-epitope, downstream of the murine ACVI. It seemed that the adenylyl cyclase might tolerate the inclusion of a large addition at the C-terminal, since the Drosophila ACI homolog carries a substantial C-terminal addition with no deleterious consequence for its activity (27) . In addition, substitution at the N terminus of aequorin does not affect its activity, whereas substitution at the C terminus eliminates Ca 2ϩ binding (28) . The strategy used to construct the full-length ACVI-aequorin chimera was first to adopt a two-stage PCR protocol to ligate the 3Ј 356 base pairs of the ACVI (13) upstream of, and in frame with, HA1-aequorin (25). This initial construct could then be readily ligated to the major 5Ј component of the ACVI cDNA. After confirming the desired sequence of the cloned PCR fusion product, the partial cyclase/aequorin chimera was religated to the remainder of the ACVI cDNA (Fig. 1) , and the full-length ACVI/AEQ cDNA was expressed in HEK 293 cells.
Since the chimera included the full coding sequence of an Ca 2ϩ -sensitive Adenylyl Cyclase/Aequorin Chimeraadenylyl cyclase, it was possible to determine whether a functional adenylyl cyclase activity was expressed and to evaluate the subcellular localization of any such activity. Thus, vector alone (control), ACVI, and ACVI/AEQ were transfected into HEK 293 cells. Cells were lysed and fractionated on a continuous sucrose gradient (Fig. 2) , and adenylyl cyclase and marker enzyme activities were assessed. Both wild type-and ACVI/ AEQ-transfected cells showed exactly the same sedimentation profile as control-transfected cells, although the adenylyl cyclase-transfected cells had 3-fold higher activities than controltransfected cells (Fig. 2) . Adenylyl cyclase activity sedimented with 5Ј-nucleotidase activity (an enzyme known to reside at the plasma membrane) and at a lighter density than the mitochondrial fraction (indicated by cytochrome c oxidase activity), which supports its appropriate plasma membrane localization. The foregoing biochemical fractionation data indicate appropriate subcellular localization of the adenylyl cyclase chimera by gross criteria and apparently unchanged overall activity. 2 The next series of experiments asked whether the full functional properties associated with ACVI were retained in the chimera. ACVI is an adenylyl cyclase that is inhibited by [Ca 2ϩ ] in the submicromolar range in vitro and inhibited strictly by capacitative Ca 2ϩ entry in vivo (11) (12) (13) 24) . The fractions corresponding to the peak adenylyl cyclase activity from sucrose gradients (viz. 32-44% sucrose; see Fig. 2 ) were pooled and sedimented, and their response to a range of EGTAbuffered Ca 2ϩ concentrations was evaluated. When the adenylyl cyclase activity in plasma membranes from either the ACVIor the ACVI/AEQ-transfected HEK 293 cells are compared, it is clear that a significant (approximately 3-fold) increment in activity is obtained over that of cells transfected with vector alone (Fig. 3A) . Strikingly, the chimeric adenylyl cyclase shows exactly the same concentration dependence for inhibition by Ca 2ϩ as the unmodified ACVI. Maximal inhibition of approximately 40% is observed at 1 M Ca 2ϩ . As an internal control for the free [Ca 2ϩ ] established in this assay, cerebral cortical membrane adenylyl cyclase activity was assayed and yielded a stimulatory response over the same range of free [Ca 2ϩ ], in keeping with the predominance of Ca 2ϩ -stimulated isoforms of adenylyl 2 Immunohistochemical experiments using a pan-cyclase antibody directed against the C terminus indicated that approximately 25% of HEK 293 cells transfected with either wild type or chimeric ACVI cDNA showed strong immunoreactivity at the cell periphery consistent with plasma membrane labeling (N. Mons and D. M. F. Cooper, unpublished observations).
FIG. 2. Adenylyl cyclase activity profiles from sucrose gradients of transfected HEK 293 cells. Cellular lysates from control-(vector alone) (E), ACVI-(q)
, and ACVI/AEQ-(f) transfected HEK 293 cells were layered on sucrose gradients and fractionated. The fractions were then analyzed for adenylyl cyclase activity, cytochrome c oxidase (CCO), 5Ј-nucleotidase (5ЈNUC), and lactate dehydrogenase (LDH) (marker enzymes for the mitochondrial, plasma membrane, and cytosolic fractions, respectively) and protein concentration. For clarity, only the peak marker enzyme activities are shown (indicated by the arrows). Peak activities for the marker enzymes occurred at 38, 33, and 5% sucrose, respectively, while the protein concentration peaked at 6.3% sucrose (not shown). ] i , is a strict dependence on capacitative Ca 2ϩ entry for their regulation in vivo, rather than release from calcium stores or nonspecific cytosolic elevation of [Ca 2ϩ ] i (9 -12) . Therefore, the most discriminating test of the appropriate cellular localization of the chimeric construct was whether it retained sensitivity to capacitative Ca 2ϩ entry. Thus, the sensitivity to capacitative Ca 2ϩ entry of the chimeric construct and the native ACVI was compared (Fig. 3B) . HEK 293 cells transfected with control vector, ACVI, or ACVI/AEQ were treated with the sarco-/endoplasmic reticulum calcium ATPase inhibitor, thapsigargin, in the absence of extracellular Ca 2ϩ to deplete inositol 1,4,5-trisphosphate-sensitive internal stores and to activate capacitative Ca 2ϩ entry mechanisms. Such a regimen has been shown previously to generate robust capacitative Ca 2ϩ entry, which in turn regulates both endogenous and transfected Ca 2ϩ -sensitive adenylyl cyclases (11, 12) . When a range of extracellular [Ca 2ϩ ] were introduced to the bathing medium to initiate capacitative Ca 2ϩ entry and the cAMP response measured, it was clear that both ACVI-and ACVI/AEQ-transfected cells showed the same (approximately 40%) maximal inhibition (Fig. 3B) . In the presence of 4 mM Ca 2ϩ , the activity of ACVI and ACVI/AEQ was reduced to 61 Ϯ 7.9% and 58 Ϯ 4%, respectively (Fig. 3B) . These values were not statistically different from each other but were quite clearly statistically different from controls, p Ͻ 0.005. These data then unequivocally establish the cellular disposition of the chimeric adenylyl cyclase and predict its probable ability to serve as a sensor of Ca 2ϩ at the plasma membrane.
The final series of experiments evaluated the ability of the adenylyl cyclase/aequorin chimera to measure [Ca 2ϩ ], both in vitro and in vivo compared with cytAEQ. An in vitro calibration curve of cytAEQ and ACVI/AEQ luminescence was fitted to EGTA-determined free [Ca 2ϩ ] (Fig. 4) . After a crude separation of cell lysate from the cell membrane fraction for use in the in vitro calibration assay, 89% of the cytAEQ luminescence activity was in the cell lysate, while 89% of the ACVI/AEQ luminescence activity was in the cell membrane fraction. The results shown in Fig. 4 To investigate whether the plasma membrane-targeted ACVI/AEQ could report changes in [Ca 2ϩ ] i in vivo, the luminescence of ACVI/AEQ and cytAEQ were evaluated in transfected HEK 293 cells under conditions of agonist-induced Ca 2ϩ -release from intracellular stores or capacitative Ca 2ϩ entry (Fig. 5) . The addition of the muscarinic cholinergic agonist, carbachol, to a suspension of HEK 293 cells transfected with either the cytAEQ or the ACVI/AEQ in the absence of extracellular Ca 2ϩ produced a rapid rise (Ͻ3 s to peak) in aequorin luminescence, which was converted to [Ca 2ϩ ] i (Fig. 5A) . Luminescence did not increase in response to carbachol in cells (n ϭ 3), respectively (Fig. 5A) . The likely explanation for this difference is the disparate location of the two Ca 2ϩ sensors within the cell, since there was no difference in their ability to measure Ca 2ϩ in vitro (Fig. 4) . 3 The plasma membrane-bound Ca 2ϩ -sensor (ACVI/AEQ) detects Ca 2ϩ , which is released from intracellular stores at a level that is considerably lower than the levels detected by the uniformly cytosolically distributed Ca 2ϩ -sensor (cytAEQ), presumably due to the reuptake into intracellular Ca 2ϩ stores and the activation of Ca 2ϩ extrusion mechanisms. If this explanation is correct, it would be predicted that the plasma membranebound ACVI/AEQ would detect higher [Ca 2ϩ ] i during Ca 2ϩ entry than the cytosolic aequorin. To evaluate this prediction, capacitative Ca 2ϩ entry was activated in HEK 293 cells transfected with either the ACVI/AEQ or the cytAEQ by adding 4 mM Ca 2ϩ to cells that had been pretreated with 100 nM thapsigargin for 10 min in nominally Ca 2ϩ -free buffer (Fig. 5B) . In support of the prediction, cells expressing the plasma membrane-bound ACVI/AEQ reported a rapid rise in [Ca 2ϩ ] i , which was consistently higher than was detected by the cytosolically distributed cytAEQ: 1225 Ϯ 117 nM versus 660 Ϯ 61 nM (n ϭ 5), respectively.
DISCUSSION
By a wide variety of criteria, the presently described adenylyl cyclase/aequorin chimera is fully functional and retains the properties of both parent molecules. The adenylyl cyclase/aequorin is localized in the same cellular regions as native ACVI; the activities of the two forms of the enzyme and their sensitivity to Ca 2ϩ , both in vitro and in vivo, are identical. Aequorin, whether free in the cytosol or tagged onto the C terminus of ACVI, has unaltered affinities and properties for responding to Ca 2ϩ and can measure [Ca 2ϩ ] i . In the intact cell, the ACVI/ AEQ reports lower concentrations of released Ca 2ϩ reaching the plasma membrane than does the cytosolically distributed cytAEQ. During capacitative Ca 2ϩ entry, however, the ACVI/ AEQ reports a much higher [Ca 2ϩ ] i at the plasma membrane than is seen by the cytosolically distributed cytAEQ. This finding is quite compatible with the reuptake, buffering, and extrusion mechanisms that are expected to reduce the amount of released Ca 2ϩ reaching microdomains within the plasma membrane and to reduce the amount of Ca 2ϩ reaching the cytosol during Ca 2ϩ influx. These data provide an explanation for the fact that capacitative influx preferentially regulates Ca 2ϩ -sensitive adenylyl cyclases rather than Ca 2ϩ released from internal stores, although global increases in [Ca 2ϩ ] i due to released Ca 2ϩ are much greater (11, 12) .
A wide variety of precise information can be anticipated from the application of this construct to a range of physiological situations. For instance, the dynamics of [Ca 2ϩ ] i in the immediate environment of a Ca 2ϩ -sensitive adenylyl cyclase and how this relates to the regulation of the enzyme can be determined. This is impossible to do with a cytosolically distributed Ca 2ϩ indicator. Along with the limitation of not being able to resolve Ca 2ϩ dynamics within a microdomain, cytosolically distributed fluorescent EGTA derivatives such as fura-2 can reach intracellular concentrations of 20 M and greater. At these concentrations, fluorescent Ca 2ϩ -indicators such as fura-2 can actually alter the true kinetics of the response by acting as a Ca 2ϩ buffer (25) . However, the concentration of a recombinantly expressed protein would be considerably lower than 1 M and would not be expected to contribute to the intracellular Ca 2ϩ buffering capacity. In addition, the cyclase chimera can serve as a novel plasma membrane-embedded [Ca 2ϩ ] i sensor, which, given the extreme dependence of Ca 2ϩ -sensitive cyclases on capacitative entry rather than release, could allow the monitoring of a very selective subpool of [Ca 2ϩ ] i .
